Verge Genomics Hiring for Engineering and Product Roles to Advance AI Drug Discovery
Verge is using AI to develop better drugs faster. We are one of the few AI drug discovery companies to advance from data to clinic – delivering two new AI-derived drugs in the last three years…
Read the full articleYou might also wanna read

Why OpenAI Researcher Miles Wang's AI Drug Discovery Startup Is Captivating Billion-Dollar Investors
Artificial intelligence has already transformed industries such as software development, finance, manufacturing, cybersecurity, and cloud co

Sightera Biosciences closes €3M pre-seed to expand its patient-derived AI drug discovery platform
Sightera Biosciences, a Belgiantechbio company using generative AI to develop novel small-molecule therapies,has raised €3 million in a pre-
OpenAI Researcher in Talks to Launch AI Drug Discovery Startup at $2B Valuation
Miles Wang, a researcher at OpenAI, is reportedly in discussions to launch a new startup focused on AI-driven drug discovery. The venture is
UK life sciences in search for AI, digital and data talent
The pharmaceutical industry is increasingly adopting new digital tools, such as artificial intelligence (AI) and big data analytics, to supp

Reversing AI drug discovery: Belgian biotech Sightera raises €3M to learn from ‘extreme’ patient biology first
Most AI drug discovery companies start by selecting a target and designing a molecule, then seeking biological validation.…
NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Accelerate Drug Discovery
NVIDIA and Eli Lilly announced an AI co-innovation lab in January, committing up to $1 billion over five years to industrialize drug discove

Comments
Sign in to join the conversation.
No comments yet. Be the first.